Thalidomide-NH-C6-NH2 TFA manufacturers
|
| | Thalidomide-NH-C6-NH2 TFA Basic information |
| Product Name: | Thalidomide-NH-C6-NH2 TFA | | Synonyms: | Thalidomide-NH-C6-NH2 TFA;Pomalidomide Related Compound 11 Triflate;4-((6-Aminohexyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 2,2,2-trifluoroacetate;1H-Isoindole-1,3(2H)-dione, 4-[(6-aminohexyl)amino]-2-(2,6-dioxo-3-piperidinyl)-, 2,2,2-trifluoroacetate (1:1) | | CAS: | 2093386-51-5 | | MF: | C21H25F3N4O6 | | MW: | 486.45 | | EINECS: | | | Product Categories: | | | Mol File: | 2093386-51-5.mol |  |
| | Thalidomide-NH-C6-NH2 TFA Chemical Properties |
| solubility | Soluble in DMSO | | form | Solid | | color | Light yellow to yellow |
| | Thalidomide-NH-C6-NH2 TFA Usage And Synthesis |
| Uses | Thalidomide-NH-C6-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. | | Biological Activity | Thalidomide-NH-C6-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. | | IC 50 | Cereblon | | References | [1]. Wang Z, et al. Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands. J Med Chem. 2019 Sep 12;62(17):8152-8163. |
| | Thalidomide-NH-C6-NH2 TFA Preparation Products And Raw materials |
|